Arix Bioscience (ARIX)

Company name:Arix Bioscience Plc
EPIC:ARIXTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BD045071
Market Segment:SSQ3Share Type:DE
WWW Address: 0.001P
 Price Price Change [%] Bid Offer Open High Low Volume
 107.50 0.0 [0.00] 105.00 110.00 107.50 107.75 107.50 39,500
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 138.87 129.18 0.05 -48.00 - - - 128.50 - 102.00

Arix Bioscience Key Figures

Key Figures
(at previous day's close)
Market Cap.138.87m
Shares In Issue129.18m
Prev. Close107.50
PE Ratio- 
Dividend Yield-%
EPS - basic-48.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-5.53p
Return On Equity (ROE)-23.89%
Operating Margin-17,965.88%
PEG Factor- 
EPS Growth Rate-149.69%
Dividends PS Growth Rate-%
Net Debt-132.51m
Gross Gearing0.67%
Quick Assets136.07m
Net Working Capital134.47m
Intangibles / Fixed Assets0.14%
Turnover PS0.26p
Pre-Tax Profit PS-47.29p
Retained Profit PS-47.22p
Cash PS103.91p
Net Cash PS102.67p
Net Tangible Asset Value PS *197.54p
Net Asset Value PS197.67p
Spread5.00 (4.55%) 

Arix Bioscience Balance Sheet

%1$s Balance Sheet

Share Price Performance

Share Price Performance
Sample Period HighLow
1 week107.75105.25
4 weeks107.75105.00
12 weeks115.50103.00
1 year128.50102.00

Share Price Chart (5 years)

Share Price Chart (5 years)

Arix Bioscience Historic Returns

%1$s Historic Returns
Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week105.502.001.90105.250.14107.22
4 weeks107.50--105.000.07106.56
12 weeks112.00-4.50-4.02103.000.07107.81
26 weeks107.50--102.000.13107.31
1 year121.50-14.00-11.52102.000.13111.64
3 years95.5012.0012.5758.500.14142.24
5 years190.00-82.50-43.4258.500.11143.19

Arix Bioscience Key Management Ratios


Arix Bioscience Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.47 
Tobin's Q Ratio (excl. intangibles)0.47 
Dividend Yield-%
Market-to-Book Ratio0.54 
Price-to-Pre-Tax Profit PS-2.27 
Price-to-Retained Profit PS-2.28 
Price-to-Cash Flow PS-19.45 
Price-to-Sales PS408.44 
Price-to-Net Tangible Asset Value PS0.54 
Price-to-Cash PS1.03 
Net Working Capital PS104.09 
Price Pct to Working Capital PS1.03%
Earnings Yield-%
Average PE3.73 
Years in average2 
PE to PE average-%

Arix Bioscience Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio0.05%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-51.54%
Net Gearing (excl. Intangibles)-51.58%
Gross Gearing0.67%
Gross Gearing (excl. Intangibles)0.67%
Gearing Under 1 Year0.62%
Gearing Under 1 Year (excl. Intgbl)0.62%
(Liquidity Ratios)
Net Working Capital to Total Assets52.31%
Current Ratio85.04 
Quick Ratio (Acid Test)85.04 
Liquidity Ratio83.89 
Cash & Equiv/Current Assets98.65%
(Solvency Ratios)
Enterprise Value4.76m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.01 
Total Debt/Sales5.06 
Total Debt/Pre-Tax Profit-0.03 
Total Debt1.72m
Total Debt/Net Current Assets0.01%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-3.73%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)

Arix Bioscience Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)-23.91%
Return On Assets (ROA)-20.75%
Net Profit Margin-17,939.12%
Assets Turnover0.00 
Return On Equity (ROE)-23.89%
Return On Investment (ROI)-20.89%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-17,939.12%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales864.40 
Debt Collection Period34,414.67Days

Arix Bioscience Dividends

Sorry No Data Available

Arix Bioscience Fundamentals

Profit and Loss Account
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
pre tax profit42.763,219.95%-75.57-126.30--61.08-m
attributable profit38.152,872.52%-69.87-126.08--60.99-m
retained profit38.152,872.52%-69.87-126.08--60.99-m
eps - basic (p)32.10 -53.80 96.60 -48.00 
eps - diluted (p)29.70 -53.80 88.60 -48.00 
dividends per share- - - - 

Arix Bioscience Balance Sheet

Balance Sheet
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
fixed assets fixed assets0.310.11%0.160.08%0.050.01%0.210.08%m
intangibles intangibles1.770.63%1.030.49%0.400.12%0.170.07%m
fixed investments fixed investments183.9865.84%152.2972.79%154.5246.72%120.6446.93%m
current assets - other current assets - other--%--%1.380.42%--%m
stocks stocks--%--%--%--%m
debtors debtors2.170.78%1.110.53%62.2818.83%1.840.72%m
cash & securities cash & securities91.2232.64%54.6426.12%112.0933.89%134.2352.21%m
creditors - short creditors - short9.283.32%6.843.27%2.240.68%1.600.62%m
creditors - long creditors - long--%0.270.13%0.270.08%0.120.05%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves270.1796.68%202.1196.60%328.2199.24%255.3699.33%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Arix Bioscience Cash Flow Statement

%1$s Cash Flow Statement
31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF-11.06-8.47-6.73-7.14m
Pre-Financing CF-126.5025.6659.5934.90m
Retained CF-44.2524.6859.5923.31m

Arix Bioscience Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Arix Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230201 12:58:03